Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Antiretroviral treatment in Sub-saharan Africa : challenges and prospects / / editors, Getnet Tizazu Fetene and Rahel Mesfin
| Antiretroviral treatment in Sub-saharan Africa : challenges and prospects / / editors, Getnet Tizazu Fetene and Rahel Mesfin |
| Pubbl/distr/stampa | Addis Ababa, Ethiopia : , : Organisation for Social Science Research in Eastern and Southern Africa (OSSREA), , 2013 |
| Descrizione fisica | 1 online resource (230 p.) |
| Disciplina | 615.79240967 |
| Soggetto topico |
AIDS (Disease) - Chemotherapy
Highly active antiretroviral therapy AIDS (Disease) - Africa, Sub-Saharanz |
| Soggetto genere / forma | Electronic books. |
| ISBN | 99944-55-78-8 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Cover; Title page; Copyright page; Contents; Acronyms; CHAPTER ONE - Introduction; CHAPTER TWO - Adherence to Antiretroviral Therapy in sub-Saharan Africa: Challenges and Prospects; Abstract; 2.1. Introduction; 2.2. Methods; 2.3. Findings; 2.4. Discussion; 2.5. Conclusion; References; CHAPTER THREE - Quality of Life among Patients Living with HIV AIDS in Sub-Saharan Africa; Abstract; 3.1. Introduction; 3.2. Methods; 3.3. Interventions to Improve QOL; 3.4. Discussion; 3.5. Limitations; 3.6. Conclusions and Recommendations; References
CHAPTER FOUR - Religion, Stigma and ART Adherence in Ethiopia: The Experience of Ethiopian Religious Associations of People Living with HIV and AIDSAbstract; 4.1. Introduction; 4.2. Literature Review; 4.3. Case Study: ETNERELA+ and Religious PLHIV Associations in Ethiopia; 4.5. Conclusions and Recommendations; Notes; References; CHAPTER FIVE - Determinants of Adherence to Antiretroviral Therapy Drugs in the Phase of Rapid Scale-up of Antiretroviral Treatment in sub-Saharan Africa: The Case of Ethiopia; Abstract; 5.1. Introduction; 5.2. Methodology; 5.3. Literature Review 5.4. Results and Discussion5.5. Conclusions; Note; References; CHAPTER SIX - Determinants of Access to Treatments by AIDS Patients in Uganda; 6.1. Introduction; 6.2. Problem Justification; 6.3. Study Objectives; 6.4. Research Questions; 6.5. Significance of the Study; 6.6. Research Methodology; 6.7. Results; 6.8. Conclusions and Policy Implications; Notes; References; CHAPTER SEVEN - Traditional Medicine and HIV and AIDS Treatment: Challenges, Prospects and Lessons for Zimbabwe; Abstract; 7.1. Introduction; 7.2. Methodology and Data Analysis; 7.3. Theoretical and Conceptual Frameworks 7.4. Review of Related Literature7.5. Findings and Discussions; 7.6. Conclusions and Recommendations; Notes; References; CHAPTER EIGHT - The Ambivalent Patient: A Study of Patients' Attitudes and Perceptions Towards ARVs and Traditional Medicines or Faith Healing for Managing HIV and AIDS Illness in Rural Harare, Zimbabwe; Abstract; 8.1. Introduction; 8.2. Literature Review; 8.3. Methodology; 8.4 Results; 8.5. Conclusions; Notes; References; CHAPTER NINE - Sexual Behaviour of People Attending Anti-retroviral Therapy in Addis Ababa; Abstract; 9.1. Introduction; 9.2. Literature Review 9.3. Research Method9.4. Results and Discussions; 9. 5. Conclusions and Implications; Notes; References; CHAPTER TEN - Concluding Remarks; Back cover |
| Record Nr. | UNINA-9910465030403321 |
| Addis Ababa, Ethiopia : , : Organisation for Social Science Research in Eastern and Southern Africa (OSSREA), , 2013 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Guidelines for the programmatic management of drug-resistant tuberculosis [[electronic resource] ] : emergency update 2008
| Guidelines for the programmatic management of drug-resistant tuberculosis [[electronic resource] ] : emergency update 2008 |
| Edizione | [Emergency update.] |
| Pubbl/distr/stampa | Geneva, : World Health Organization, Stop TB Department, c2008 |
| Descrizione fisica | 1 online resource (270 p.) |
| Disciplina | 615.58 |
| Altri autori (Persone) | JaramilloErnesto |
| Soggetto topico |
Antitubercular agents
Comorbidity - Treatment Highly active antiretroviral therapy HIV infections - Chemotherapy Multidrug-resistant tuberculosis - Chemotherapy Multidrug-resistant tuberculosis - Prevention |
| ISBN |
1-282-05799-5
9786612057991 92-4-068353-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
COVER; COPYRIGHT; CONTENTS; Acknowledgements; Abbreviations; Executive summary; Foreword to the 2008 emergency updated edition; CHAPTER 1: Background information on DR-TB; CHAPTER 2: Framework for effective control of DR-TB; CHAPTER 3: Political commitment and coordination; CHAPTER 4: Definitions:case registration, bacteriology and treatment outcomes; CHAPTER 5: Case-finding strategies; CHAPTER 6: Laboratory aspects; CHAPTER 7: Treatment strategies for MDR-TB and XDR-TB; CHAPTER 8: Mono-resistant and poly-resistant strains; CHAPTER 9: Treatment of DR-TB in special conditions and situations
CHAPTER 10: DR-TB and HIV infectionCHAPTER 11: Initial evaluation, monitoring of treatment and management of adverse effects; CHAPTER 12: Treatment delivery and community-based DR-TB support; Chapter 13: Management of patients after MDR-TB treatment failure; CHAPTER 14: Management of contacts of MDR-TB patients; CHAPTER 15: Drug resistance and infection control; CHAPTER 16: Human resources:training and staffing; CHAPTER 17: Management of second-line antituberculosis drugs; CHAPTER 18: Category IV recording and reporting system; CHAPTER 19: Managing DR-TB through patient-centred care ANNEX 1: Drug information sheetsANNEX 2: Weight-based dosing of drugs for adults; ANNEX 3: Suggestions for further reading; ANNEX 4: Legislation, human rights and patients' rights in tuberculosis prevention and control; ANNEX 5: Use of experimental drugs outside of clinical trials ("compassionate use"); ANNEX 6: Methodology; FORMS; INDEX; BACK COVER |
| Record Nr. | UNISA-996320228203316 |
| Geneva, : World Health Organization, Stop TB Department, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Guidelines for the programmatic management of drug-resistant tuberculosis : emergency update 2008
| Guidelines for the programmatic management of drug-resistant tuberculosis : emergency update 2008 |
| Edizione | [Emergency update.] |
| Pubbl/distr/stampa | Geneva, : World Health Organization, Stop TB Department, c2008 |
| Descrizione fisica | 1 online resource (270 p.) |
| Disciplina | 615.58 |
| Soggetto topico |
Antitubercular agents
Comorbidity - Treatment Highly active antiretroviral therapy HIV infections - Chemotherapy Multidrug-resistant tuberculosis - Chemotherapy Multidrug-resistant tuberculosis - Prevention |
| ISBN |
1-282-05799-5
9786612057991 92-4-068353-4 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
COVER; COPYRIGHT; CONTENTS; Acknowledgements; Abbreviations; Executive summary; Foreword to the 2008 emergency updated edition; CHAPTER 1: Background information on DR-TB; CHAPTER 2: Framework for effective control of DR-TB; CHAPTER 3: Political commitment and coordination; CHAPTER 4: Definitions:case registration, bacteriology and treatment outcomes; CHAPTER 5: Case-finding strategies; CHAPTER 6: Laboratory aspects; CHAPTER 7: Treatment strategies for MDR-TB and XDR-TB; CHAPTER 8: Mono-resistant and poly-resistant strains; CHAPTER 9: Treatment of DR-TB in special conditions and situations
CHAPTER 10: DR-TB and HIV infectionCHAPTER 11: Initial evaluation, monitoring of treatment and management of adverse effects; CHAPTER 12: Treatment delivery and community-based DR-TB support; Chapter 13: Management of patients after MDR-TB treatment failure; CHAPTER 14: Management of contacts of MDR-TB patients; CHAPTER 15: Drug resistance and infection control; CHAPTER 16: Human resources:training and staffing; CHAPTER 17: Management of second-line antituberculosis drugs; CHAPTER 18: Category IV recording and reporting system; CHAPTER 19: Managing DR-TB through patient-centred care ANNEX 1: Drug information sheetsANNEX 2: Weight-based dosing of drugs for adults; ANNEX 3: Suggestions for further reading; ANNEX 4: Legislation, human rights and patients' rights in tuberculosis prevention and control; ANNEX 5: Use of experimental drugs outside of clinical trials ("compassionate use"); ANNEX 6: Methodology; FORMS; INDEX; BACK COVER |
| Record Nr. | UNINA-9910145965203321 |
| Geneva, : World Health Organization, Stop TB Department, c2008 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
